Eli Lilly and its subsidiary, Avid Radiopharmaceuticals, have announced that the European Commission has approved Amyvid (Florbetapir (18F)) solution for injection as a diagnostic radiopharmaceutical.

Objectives Recent reports suggest that florbetapir F18 (AV-45) is a new PET imaging agent targeting Aβ aggregates in the brain of patient with Alzheimer’s disease. Similarly, accumulation of Aβ ...

Whole brain anatomical T1-MPRAGE or IR-SPGR MRI (Slice thickness 1–1.2 mm; TR, 2300–3000 ms; TE 2.9–3.5 ms; FoV, 256×256 cm 2) and 18F-florbetapir Aβ-PET (AV45) and 18F-flortaucipir (AV-1451) tau-PET ...

Cerebral amyloid angiopathy (CAA) is driven by vascular Aβ (amyloid‐beta) deposition, which can be detected as reduced Aβ species in cerebrospinal fluid (CSF). We sought to identify relationships ...

2 Department of Radiology, VU University Medical Centre, Amsterdam, Netherlands 3 Department of Neurology, VU University Medical Centre, Amsterdam, Netherlands Correspondence to Professor Nick C Fox, ...